$CMRX
CHIMERIX INC Stock $cmrx

$cmrx Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000111748015000024 Filed on November 05, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$3.110M	$2.271M	$1.185M
YoY Change	169.03%	91.65%	29.93%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$9.760M	$8.613M	$4.717M
YoY Change	70.63%	82.59%	132.36%
% of Gross Profit
Research & Development	$31.58M	$26.50M	$13.33M
YoY Change	101.53%	98.79%	150.53%
% of Gross Profit
Depreciation & Amortization	$220.0K	$180.0K	$80.00K
YoY Change	120.0%	125.0%	33.33%
% of Gross Profit
Operating Expenses	$41.33M	$35.02M	$18.05M
YoY Change	93.31%	94.06%	145.51%
Operating Profit	-$38.22M	-$32.75M	-$16.86M
YoY Change	88.98%	94.23%	161.96%
Interest Expense	$380.0K	$300.0K	-$90.00K
YoY Change	-2000.0%	-433.33%	-66.67%
% of Operating Profit
Other Income/Expense, Net	$0.00		$0.00
YoY Change
Pretax Income	-$37.84M	-$32.45M	-$16.95M
YoY Change	86.86%	91.45%	152.61%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$37.84M	-$32.45M	-$16.95M
YoY Change	86.9%	91.43%	152.77%
Net Earnings / Revenue	-1216.78%	-1428.84%	-1430.46%
Basic Earnings Per Share
Diluted Earnings Per Share	-$819.4K	-$704.5K	-$472.8K
COMMON SHARES
Basic Shares Outstanding	46.15M shares	46.07M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$220.3M	$220.8M	$188.4M
YoY Change	-6.1%	17.2%	61.16%
Cash & Equivalents	$20.61M	$44.72M	$74.35M
Short-Term Investments	$199.7M	$176.1M	$114.1M
Other Short-Term Assets	$851.0K	$8.200M	$3.500M
YoY Change	336.41%	134.29%	29.63%
Inventory
Prepaid Expenses
Receivables	$2.432M	$525.0K	$900.0K
Other Receivables	$700.0K	$0.00	$0.00
Total Short-Term Assets	$228.8M	$229.5M	$192.9M
YoY Change	-3.63%	18.98%	61.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.045M	$2.439M	$1.100M
YoY Change	132.44%	121.73%	266.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$124.0M	$159.5M
YoY Change	133.96%
Other Assets	$70.00K	$75.00K	$0.00
YoY Change	-49.28%
Total Long-Term Assets	$127.2M	$162.0M	$1.100M
YoY Change	133.65%	14627.27%	175.0%
TOTAL ASSETS
Total Short-Term Assets	$228.8M	$229.5M	$192.9M
Total Long-Term Assets	$127.2M	$162.0M	$1.100M
Total Assets	$356.0M	$391.5M	$194.0M
YoY Change	21.97%	101.81%	61.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.46M	$12.92M	$5.800M
YoY Change	76.12%	122.74%	222.22%
Accrued Expenses	$9.721M	$7.782M	$5.300M
YoY Change	42.27%	46.83%	231.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$400.0K	$5.300M
YoY Change	-100.0%	-92.45%	-5.36%
Total Short-Term Liabilities	$20.18M	$21.08M	$16.50M
YoY Change	18.23%	27.73%	83.33%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$400.0K
YoY Change		-100.0%	-92.98%
Other Long-Term Liabilities	$354.0K	$221.0K	$500.0K
YoY Change	102.29%	-55.8%	66.67%
Total Long-Term Liabilities	$354.0K	$221.0K	$900.0K
YoY Change	102.29%	-75.44%	-85.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.18M	$21.08M	$16.50M
Total Long-Term Liabilities	$354.0K	$221.0K	$900.0K
Total Liabilities	$20.53M	$21.30M	$17.40M
YoY Change	19.09%	22.4%	16.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$339.4M	-$301.6M
YoY Change	52.86%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$335.5M	$370.2M	$176.6M
YoY Change
Total Liabilities & Shareholders Equity	$356.0M	$391.5M	$194.0M
YoY Change	21.97%	101.81%	61.4%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	-$37.84M	-$32.45M	-$16.95M
YoY Change	86.9%	91.43%	152.77%
Depreciation, Depletion And Amortization	$220.0K	$180.0K	$80.00K
YoY Change	120.0%	125.0%	33.33%
Cash From Operating Activities	-$32.92M	-$24.93M	-$11.45M
YoY Change	95.02%	117.73%	122.76%
INVESTING ACTIVITIES
Capital Expenditures	-$820.0K	-$620.0K	-$470.0K
YoY Change	156.25%	31.91%	683.33%
Acquisitions
YoY Change
Other Investing Activities	$10.14M	-$57.49M	-$33.47M
YoY Change	-123.15%	71.77%	-610.99%
Cash From Investing Activities	$9.310M	-$58.11M	-$33.94M
YoY Change	-121.1%	71.21%	-622.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-510.0K	-10.00K	140.0K
YoY Change	-100.44%	-107.14%	-115.56%
NET CHANGE
Cash From Operating Activities	-32.92M	-24.93M	-11.45M
Cash From Investing Activities	9.310M	-58.11M	-33.94M
Cash From Financing Activities	-510.0K	-10.00K	140.0K
Net Change In Cash	-24.12M	-83.05M	-45.25M
YoY Change	-144.58%	83.54%	-10155.56%
FREE CASH FLOW
Cash From Operating Activities	-$32.92M	-$24.93M	-$11.45M
Capital Expenditures	-$820.0K	-$620.0K	-$470.0K
Free Cash Flow	-$32.10M	-$24.31M	-$10.98M
YoY Change	93.84%	121.4%	116.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	1116000	USD
CY2015Q3	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	2604000	USD
CY2015Q3	cmrx	Availablefor Sale Securities Debt Maturities Year Onethrough Two Fair Value AvailableforSaleSecuritiesDebtMaturitiesYearOnethroughTwoFairValue	159486000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001117480
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46146101	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CHIMERIX INC
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5938000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	12919000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	106000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	525000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-734000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1186000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6833000	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7782000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1574000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	498000	USD
	us-gaap	Interest Paid Net InterestPaidNet	552000	USD
	us-gaap	Interest Paid Net InterestPaidNet	156000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	356000	USD
CY2014Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	3057000	USD
CY2015Q3	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	3080000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	35000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	496602000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	671380000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1362000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2777000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3679000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8882000	USD
	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	0	USD
	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	4000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	118000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	64000	USD
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2093000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2406000	shares
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1113000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1278000	shares
CY2014Q4	us-gaap	Assets Assets	291878000	USD
CY2015Q3	us-gaap	Assets Assets	391508000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	237457000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	229508000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	159087000	USD
CY2015Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	335566000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	237000	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	476000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	202000	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	12000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	159052000	USD
CY2015Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	335102000	USD
CY2014Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	106114000	USD
CY2015Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	176080000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	333724000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	174238000	USD
CY2014Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	52973000	USD
CY2015Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	159486000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109976000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74350000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	128462000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44720000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-35626000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-83742000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41031770	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46142340	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41031770	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46142340	shares
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	41000	USD
CY2015Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2014Q3	us-gaap	Contracts Revenue ContractsRevenue	1185000	USD
	us-gaap	Contracts Revenue ContractsRevenue	2884000	USD
CY2015Q3	us-gaap	Contracts Revenue ContractsRevenue	2271000	USD
	us-gaap	Contracts Revenue ContractsRevenue	6104000	USD
CY2014Q4	us-gaap	Deferred Revenue DeferredRevenue	1545000	USD
CY2015Q3	us-gaap	Deferred Revenue DeferredRevenue	0	USD
	us-gaap	Depreciation Depreciation	183000	USD
	us-gaap	Depreciation Depreciation	444000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.47
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.26
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.84
CY2014Q4	us-gaap	Fair Value Assumptions Exercise Price FairValueAssumptionsExercisePrice	2.22
CY2015Q3	us-gaap	Fair Value Assumptions Exercise Price FairValueAssumptionsExercisePrice	2.09
CY2014Q4	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
CY2015Q3	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
CY2014Q4	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P1Y6M
CY2015Q3	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P255D
CY2014Q4	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.65
CY2015Q3	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.65
CY2014Q4	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0044
CY2015Q3	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0021
CY2014Q4	us-gaap	Fair Value Inputs Discount For Lack Of Marketability FairValueInputsDiscountForLackOfMarketability	0.25
CY2015Q3	us-gaap	Fair Value Inputs Discount For Lack Of Marketability FairValueInputsDiscountForLackOfMarketability	0.18
	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Period FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod	P18M
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6483000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7931000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	654000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	419000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	780000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5354000	USD
CY2014Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-91000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-425000	USD
CY2015Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	299000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	17242000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	21297000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	291878000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	391508000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17067000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	21076000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1448000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	321000	USD
CY2014Q3	us-gaap	Licenses Revenue LicensesRevenue	0	USD
	us-gaap	Licenses Revenue LicensesRevenue	0	USD
CY2015Q3	us-gaap	Licenses Revenue LicensesRevenue	0	USD
	us-gaap	Licenses Revenue LicensesRevenue	1548000	USD
CY2012Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	15000000	USD
CY2014Q4	us-gaap	Loans Payable Current LoansPayableCurrent	4296000	USD
CY2015Q3	us-gaap	Loans Payable Current LoansPayableCurrent	375000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	110150000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	161858000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-115572000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-178809000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-30204000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-66791000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-16951000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39065000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-32449000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-79529000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	18045000	USD
	us-gaap	Operating Expenses OperatingExpenses	41524000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	35019000	USD
	us-gaap	Operating Expenses OperatingExpenses	87679000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-16860000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-38640000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-32748000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-80027000	USD
CY2014Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	100000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	400000	USD
CY2015Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	500000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1115000	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2098000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	138000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	75000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-43000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-63000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-16994000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-39128000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-33897000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-79208000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-222042000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	175000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	221000	USD
CY2014Q3	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2015Q3	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	212766000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	703000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	138058000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	56294000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q3	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2775000	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8183000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	111845000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	161880000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	426000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	1054000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	20690000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	90822000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-68000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2499000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1003000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2148000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1967000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6000	USD
CY2015Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1000000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1310000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2439000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4275000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	3975000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13328000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29712000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26406000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	65611000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-301571000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11812000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8613000	USD
CY2014Q3	us-gaap	Revenues Revenues	1185000	USD
	us-gaap	Revenues Revenues	2884000	USD
CY2015Q3	us-gaap	Revenues Revenues	2271000	USD
	us-gaap	Revenues Revenues	7652000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4717000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22068000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2777000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8882000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	274636000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	370211000	USD
CY2015Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	35845792	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	30939752	shares
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46059112	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	43112314	shares

Files In Submission

Name	View Source	Status
0001117480-15-000024-index-headers.html	Edgar Link	pending
0001117480-15-000024-index.html	Edgar Link	pending
0001117480-15-000024.txt	Edgar Link	pending
0001117480-15-000024-xbrl.zip	Edgar Link	pending
a20150930cmrx10-qdocument.htm	Edgar Link	pending
a20150930cmrxex-102.htm	Edgar Link	pending
a20150930cmrxex-103.htm	Edgar Link	pending
a20150930cmrxex-311.htm	Edgar Link	pending
a20150930cmrxex-312.htm	Edgar Link	pending
a20150930cmrxex-321.htm	Edgar Link	pending
a20150930cmrxex-322.htm	Edgar Link	pending
cmrx-20150930.xml	Edgar Link	completed
cmrx-20150930.xsd	Edgar Link	pending
cmrx-20150930_cal.xml	Edgar Link	unprocessable
cmrx-20150930_def.xml	Edgar Link	unprocessable
cmrx-20150930_lab.xml	Edgar Link	unprocessable
cmrx-20150930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMRX
CHIMERIX INC Stock $cmrx

2015 Q4 Form 10-Q Financial Statement

#000111748015000024 Filed on November 05, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX CHIMERIX INC Stock $cmrx

2015 Q4 Form 10-Q Financial Statement

#000111748015000024 Filed on November 05, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX
CHIMERIX INC Stock $cmrx